Specifically, HAS1 expression was strongly increased in LR-MDS and remained above control levels in HR-MDS (Figure 4A), while HAS2 was up-regulated specifically in LR-MDS, being comparatively low in both healthy donor and HR-MDS MSCs (Figure 4B). This evidence concerns the gene HAS2 and myelodysplastic syndrome.